Effect of a Comprehensive Corrective Exercise Program With and Without Instrument-Assisted Soft Tissue Mobilization on Cervical Range of Motion, Muscle Strength, Disability, and Postural Alignment in Individuals With Upper-Crossed Syndrome

NCT07702604 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2026-07-22

No results posted yet for this study

Summary

This study is a double-blind, parallel-group randomized controlled trial designed to evaluate the effectiveness of a Comprehensive Corrective Exercise Program (CCEP) with and without Instrument-Assisted Soft Tissue Mobilization (IASTM) in individuals with Upper-Crossed Syndrome (UCS). UCS is a common postural dysfunction characterized by muscular imbalance, including tightness of the upper trapezius, levator scapulae, and pectoral muscles, along with weakness of the deep cervical flexors and scapular stabilizers. This imbalance leads to forward head posture, rounded shoulders, neck pain, reduced cervical mobility, and functional limitations, particularly in individuals exposed to prolonged sedentary activities and poor ergonomic conditions.

A total of 60 participants aged 18-40 years diagnosed with Upper-Crossed Syndrome will be recruited and randomly allocated into two groups. The control group will receive a structured Comprehensive Corrective Exercise Program (CCEP), while the experimental group will receive the same exercise program combined with Instrument-Assisted Soft Tissue Mobilization (IASTM).

Both interventions will be administered three times per week for six weeks under the supervision of a trained physiotherapist. Outcome measures will be assessed at baseline and after completion of the intervention period. Primary outcomes include cervical range of motion, muscle strength assessed by the Deep Neck Flexor endurance test, functional disability measured using the Neck Disability Index, and postural alignment assessed using a plumb line method.

The aim of this study is to determine whether the addition of IASTM to a corrective exercise program results in superior improvements in cervical mobility, muscle strength, functional disability, and postural alignment compared to corrective exercise alone. It is hypothesized that the combined intervention will produce greater clinical improvements in individuals with Upper-Crossed Syndrome.

Conditions

  • Upper Crossed Syndrome
  • Postural Dysfunction

Interventions

OTHER

Instrument-Assisted Soft Tissue Mobilization (IASTM) + Comprehensive Corrective Exercise Program (CCEP)

This intervention combines the Comprehensive Corrective Exercise Program (CCEP) with Instrument-Assisted Soft Tissue Mobilization (IASTM). The exercise component is identical to the control group and includes stretching, strengthening, and postural re-education exercises targeting cervical and scapular musculature. IASTM is applied to overactive muscles including upper trapezius, levator scapulae, sternocleidomastoid, and pectoral muscles using specialized instruments with techniques such as scanning, sweeping, J-stroke, and fanning. Each session lasts approximately 20 minutes, administered three times per week for six weeks under physiotherapist supervision.

OTHER

Comprehensive Corrective Exercise Program (CCEP)

The Comprehensive Corrective Exercise Program (CCEP) is a structured physiotherapy intervention designed to correct muscular imbalance associated with Upper-Crossed Syndrome. It includes stretching of overactive muscles (pectoralis major and minor, upper trapezius, levator scapulae, sternocleidomastoid), strengthening of weak muscles (deep cervical flexors, lower trapezius, rhomboids, serratus anterior), and motor control and postural re-education exercises. Exercises are performed under physiotherapist supervision three times per week for six weeks.

Sponsors & Collaborators

  • Lahore University of Biological and Applied Sciences

    lead OTHER

Principal Investigators

  • Shoaib Waqas, PhD · Lahore University of Biological and Applied Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-16
Primary Completion
2026-10-30
Completion
2026-11-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07702604 on ClinicalTrials.gov